$RGNX stock has now fallen 18% today, according to our price data from Polygon. There has been approximately $11,676,399 of trading volume.
It has been the 734th most-searched ticker on Quiver Quantitative over the last day, out of 10,568 total tickers searched.
Here is what we see in our data on $RGNX (you can track the company live on Quiver's $RGNX stock page):
$RGNX Insider Trading Activity
$RGNX insiders have traded $RGNX stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $RGNX stock by insiders over the last 6 months:
- CURRAN SIMPSON (Chief Executive Officer) has made 0 purchases and 3 sales selling 36,169 shares for an estimated $416,598.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$RGNX Hedge Fund Activity
We have seen 90 institutional investors add shares of $RGNX stock to their portfolio, and 65 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BALYASNY ASSET MANAGEMENT L.P. removed 797,100 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $7,692,015
- MORGAN STANLEY added 709,512 shares (+71.3%) to their portfolio in Q3 2025, for an estimated $6,846,790
- ASSENAGON ASSET MANAGEMENT S.A. added 454,977 shares (+64.5%) to their portfolio in Q4 2025, for an estimated $6,551,668
- INVENOMIC CAPITAL MANAGEMENT LP added 426,904 shares (+inf%) to their portfolio in Q3 2025, for an estimated $4,119,623
- RENAISSANCE TECHNOLOGIES LLC removed 425,714 shares (-57.9%) from their portfolio in Q3 2025, for an estimated $4,108,140
- INTEGRAL HEALTH ASSET MANAGEMENT, LLC added 400,000 shares (+57.1%) to their portfolio in Q3 2025, for an estimated $3,860,000
- BLACKROCK, INC. removed 388,200 shares (-5.7%) from their portfolio in Q3 2025, for an estimated $3,746,130
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$RGNX Analyst Ratings
Wall Street analysts have issued reports on $RGNX in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Stifel issued a "Buy" rating on 12/19/2025
- Chardan Capital issued a "Buy" rating on 11/20/2025
- RBC Capital issued a "Outperform" rating on 11/07/2025
- HC Wainwright & Co. issued a "Buy" rating on 10/07/2025
To track analyst ratings and price targets for $RGNX, check out Quiver Quantitative's $RGNX forecast page.
$RGNX Price Targets
Multiple analysts have issued price targets for $RGNX recently. We have seen 7 analysts offer price targets for $RGNX in the last 6 months, with a median target of $20.0.
Here are some recent targets:
- Daniil Gataulin from Chardan Capital set a target price of $50.0 on 02/10/2026
- Paul Choi from Goldman Sachs set a target price of $12.0 on 02/10/2026
- Judah Frommer from Morgan Stanley set a target price of $18.0 on 02/10/2026
- Annabel Samimy from Stifel set a target price of $45.0 on 12/19/2025
- Mani Foroohar from Leerink Partners set a target price of $20.0 on 12/15/2025
- Luca Issi from RBC Capital set a target price of $19.0 on 11/07/2025
- Yi Chen from HC Wainwright & Co. set a target price of $34.0 on 10/07/2025
You can track data on $RGNX on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
